Oncology

FLAURA Trial: OS Results Confirm TKI As Preferred First-Line Therapy for EGFRm NSCLC

Glenwood Goss, MD

University of Ottawa & The Ottawa Hospital

Respirology

Real World Benefits in the Treatment of Severe Allergic Asthma: The STELLAIR Study

Warren Ramesh, MD

University of Alberta & Royal Alexandra Hospital

Neurology

Early Use of DMT is Pivotal to RRMS Patient Outcome

Anthony Traboulsee, MD

University of British Columbia 

Cardiology

Patients with HFpEF: Findings from the PARAGON-HF Trial

Anique Ducharme, MD, MSc, FRCP 

Université de Montréal & Montréal Heart Institute

Neurology

Secondary Progressive Multiple Sclerosis (SPMS): The Road Ahead

Mark S. Freedman, MSC, MD
CSPQ, FANA, FAAN, FRCPC
Professor of Medicine, Neurology
The Ottawa Hospital
Ottawa, Ontario